Vai al contenuto principale della pagina

Cancer Policy: Pharmaceutical Safety [[electronic resource] /] / edited by June M. McKoy, Dennis P. West



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Titolo: Cancer Policy: Pharmaceutical Safety [[electronic resource] /] / edited by June M. McKoy, Dennis P. West Visualizza cluster
Pubblicazione: Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019
Edizione: 1st ed. 2019.
Descrizione fisica: 1 online resource (129 pages)
Disciplina: 615.10289
Soggetto topico: Oncology  
Pharmacy
Oncology
Drug Safety and Pharmacovigilance
Persona (resp. second.): McKoyJune M
WestDennis P
Nota di contenuto: Pharmacovigilance programs: Do they improve Cancer Drug Safety? -- Impact of Cost on the Safety of Cancer pharmaceuticals -- Assessing pharmaceutical safety in Geriatric Oncology -- Cancer co-Morbidity: Implications for Drug Safety -- Statistical aids to signal generation: Are they effective in Identifying Adverse Cancer Drug Reactions? -- Pharmacovigilance of alternative medications in the Cancer Setting -- Key elements in Adverse Drug Interaction Safety Signals: evaluation of individual case reports in oncology -- Biosimilars: Are they really safe? -- Natural Language processing: improving the identification and communication of Cancer Drug Safety -- The Drug Shortage Crisis in the United States: Impact on cancer pharmaceutical safety -- Anatomy of Risk Evaluation and Mitigation Strategies (REMS) -- Cancer Drug Toxicity: Moving from patient to Survivor.
Sommario/riassunto: Cancer Policy: Pharmaceutical Safety provides invaluable information on the interesting and compelling field of cancer drug safety. Identifying and understanding high-priority policy issues and key pharmacovigilance strategies is of paramount importance. In this volume, outstanding and original chapters provide an overview and synthesis of the latest thoughts and findings relating to drug safety in the cancer domain. Topics include natural language processing and pharmacovigilance of alternative cancer pharmaceuticals. The information presented in this volume will improve understanding of emerging strategies to identify adverse drug reactions and drug-drug interactions within the cancer setting and will highlight policies that have been instituted to improve cancer patient safety. In summary, Cancer Policy: Pharmaceutical Safety explores many of the important areas of pharmacovigilance research in oncology.
Titolo autorizzato: Cancer Policy  Visualizza cluster
ISBN: 3-319-43896-4
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910337507003321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Serie: Cancer Treatment and Research, . 0927-3042 ; ; 171